SEC 13F Intelligence

Rock Springs Capital Management LP / KYMR

Rock Springs Capital Management LP’s Kymera Therapeutics Inc Position

Does Rock Springs Capital Management LP own Kymera Therapeutics Inc (KYMR)? Yes496.9K shares worth $41M (+2.44% of its 13F portfolio) as of Q1 2026.

Position Value
$41M
Q1 2026
Shares
496.9K
% of Portfolio
+2.44%
Quarters Held
23
currently held

Position History KYMR

Reported value by quarter
Q3 ’20: $23MQ3 ’20Q4 ’20: $44MQ1 ’21: $24MQ2 ’21: $30MQ2 ’21Q3 ’21: $43MQ4 ’21: $47MQ1 ’22: $32MQ1 ’22Q2 ’22: $15MQ3 ’22: $23MQ4 ’22: $31MQ4 ’22Q1 ’23: $36MQ2 ’23: $34MQ3 ’23: $21MQ3 ’23Q4 ’23: $39MQ1 ’24: $61MQ2 ’24: $35MQ2 ’24Q3 ’24: $50MQ4 ’24: $42MQ1 ’25: $22MQ1 ’25Q2 ’25: $20MQ3 ’25: $25MQ4 ’25: $39MQ4 ’25Q1 ’26: $41Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026496.9K$41M+2.44%
Q4 2025496.9K$39M+1.98%
Q3 2025450.4K$25M+1.49%
Q2 2025450.4K$20M+1.22%
Q1 2025794.4K$22M+1.24%
Q4 20241.03M$42M+1.58%
Q3 20241.05M$50M+1.62%
Q2 20241.16M$35M+1.05%
Q1 20241.52M$61M+1.55%
Q4 20231.52M$39M+0.95%
Q3 20231.50M$21M+0.56%
Q2 20231.49M$34M+0.81%
Q1 20231.23M$36M+0.87%
Q4 20221.23M$31M+0.74%
Q3 20221.05M$23M+0.59%
Q2 2022775.9K$15M+0.44%
Q1 2022755.9K$32M+0.81%
Q4 2021742.1K$47M+1.09%
Q3 2021732.9K$43M+0.91%
Q2 2021626.5K$30M+0.60%
Q1 2021621.8K$24M+0.53%
Q4 2020713.9K$44M+0.94%
Q3 2020710.0K$23M+0.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of KYMR.